DE2721785A1 - Oral verabfolgbares cephalexinpraeparat mit verzoegerter wirkstoffabgabe - Google Patents

Oral verabfolgbares cephalexinpraeparat mit verzoegerter wirkstoffabgabe

Info

Publication number
DE2721785A1
DE2721785A1 DE19772721785 DE2721785A DE2721785A1 DE 2721785 A1 DE2721785 A1 DE 2721785A1 DE 19772721785 DE19772721785 DE 19772721785 DE 2721785 A DE2721785 A DE 2721785A DE 2721785 A1 DE2721785 A1 DE 2721785A1
Authority
DE
Germany
Prior art keywords
cephalexin
preparation
preparation according
hours
antibiotic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE19772721785
Other languages
German (de)
English (en)
Other versions
DE2721785C2 (da
Inventor
Hiroshi Kato
Hideyuki Maekawa
Yasushi Takagishi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Publication of DE2721785A1 publication Critical patent/DE2721785A1/de
Application granted granted Critical
Publication of DE2721785C2 publication Critical patent/DE2721785C2/de
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cephalosporin Compounds (AREA)
DE19772721785 1976-05-13 1977-05-13 Oral verabfolgbares cephalexinpraeparat mit verzoegerter wirkstoffabgabe Granted DE2721785A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5492576A JPS52139713A (en) 1976-05-13 1976-05-13 Sustained release cefalexin preparations

Publications (2)

Publication Number Publication Date
DE2721785A1 true DE2721785A1 (de) 1977-11-24
DE2721785C2 DE2721785C2 (da) 1989-03-16

Family

ID=12984185

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19772721785 Granted DE2721785A1 (de) 1976-05-13 1977-05-13 Oral verabfolgbares cephalexinpraeparat mit verzoegerter wirkstoffabgabe

Country Status (27)

Country Link
JP (1) JPS52139713A (da)
AR (1) AR224494A1 (da)
AT (1) AT351159B (da)
AU (1) AU508793B2 (da)
BE (1) BE854640A (da)
CA (1) CA1085296A (da)
CS (1) CS208196B2 (da)
DD (1) DD132232A5 (da)
DE (1) DE2721785A1 (da)
DK (1) DK208077A (da)
ES (1) ES458710A1 (da)
FI (1) FI771491A (da)
FR (1) FR2350836A1 (da)
GB (1) GB1543543A (da)
GR (1) GR68895B (da)
HU (1) HU184196B (da)
IE (1) IE45415B1 (da)
IL (1) IL52075A (da)
MX (1) MX5976E (da)
NL (1) NL7704879A (da)
NZ (1) NZ183927A (da)
PL (1) PL111183B1 (da)
PT (1) PT66514B (da)
RO (1) RO72935A (da)
SE (1) SE426780B (da)
SU (1) SU1218919A3 (da)
ZA (1) ZA772757B (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5545601A (en) * 1978-09-26 1980-03-31 Toyo Jozo Co Ltd Long-acting cephalexin and its preparation
FR2453639A1 (fr) * 1979-04-09 1980-11-07 Sanofi Sa Composition medicamenteuse a liberation programmee immediate-retard a base de naftidrofuryl
JPS5659707A (en) * 1979-10-19 1981-05-23 Toyo Jozo Co Ltd Lasting antibiotic pharmaceutical and its preparation
JPS5826816A (ja) * 1981-08-11 1983-02-17 Teisan Seiyaku Kk 球形顆粒からなる持続性複合顆粒剤
JPS5846019A (ja) * 1981-09-14 1983-03-17 Kanebo Ltd 持続性ニフエジピン製剤
JPS5883613A (ja) * 1981-11-10 1983-05-19 Toa Eiyou Kagaku Kogyo Kk 硝酸イソソルビト−ル製剤
JPS5883106U (ja) * 1981-11-30 1983-06-06 松下電工株式会社 電磁石装置に於けるオイルダツシユポツト
US4525339A (en) * 1982-10-15 1985-06-25 Hoffmann-La Roche Inc. Enteric coated oral dosage form
JPS601128A (ja) * 1983-06-15 1985-01-07 Shionogi & Co Ltd 作用持続型セフアクロル製剤
JPS6144811A (ja) * 1984-08-10 1986-03-04 Ss Pharmaceut Co Ltd 徐放性ジクロフエナクナトリウム製剤
FR2577800B1 (fr) * 1985-02-22 1990-09-07 Grimberg Georges Medicament sous forme galenique gastro-resistante
JPS62226926A (ja) * 1986-03-27 1987-10-05 Teisan Seiyaku Kk 持続性複合顆粒剤
EA200702221A1 (ru) * 2005-04-12 2008-04-28 Элан Фарма Интернэшнл Лимитед Композиции с контролируемым высвобождением для лечения бактериальной инфекции, содержащие цефалоспорин
CN114617855A (zh) * 2020-12-14 2022-06-14 江苏贝佳制药有限公司 头孢氨苄胶囊的制备方法

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
FIEDLER, H.P.: Lexikon der Hilfsstoffe, 1971, 203-204 *
GSTIRNER, F.: Einführung in die Verfahrenstechnik der Arzneiformung, 1973, 234-239 *
RITSCHEL, W.A.: Angewandte Biopharmazie, 1973, 417-418 *

Also Published As

Publication number Publication date
SE7705502L (sv) 1977-11-14
RO72935A (ro) 1982-07-06
DE2721785C2 (da) 1989-03-16
SU1218919A3 (ru) 1986-03-15
PL111183B1 (en) 1980-08-30
JPS5547611B2 (da) 1980-12-01
AU508793B2 (en) 1980-04-03
FR2350836A1 (fr) 1977-12-09
DK208077A (da) 1977-11-14
ES458710A1 (es) 1978-03-01
JPS52139713A (en) 1977-11-21
GR68895B (da) 1982-03-15
HU184196B (en) 1984-07-30
MX5976E (es) 1984-09-12
BE854640A (fr) 1977-09-01
CS208196B2 (en) 1981-08-31
AT351159B (de) 1979-07-10
ATA341877A (de) 1978-12-15
FI771491A (da) 1977-11-14
PT66514A (en) 1977-06-01
PT66514B (en) 1978-10-16
IL52075A (en) 1980-06-30
IL52075A0 (en) 1977-07-31
ZA772757B (en) 1978-04-26
DD132232A5 (de) 1978-09-13
IE45415B1 (en) 1982-08-25
AR224494A1 (es) 1981-12-15
IE45415L (en) 1977-11-13
SE426780B (sv) 1983-02-14
NL7704879A (nl) 1977-11-15
FR2350836B1 (da) 1981-02-06
GB1543543A (en) 1979-04-04
AU2507877A (en) 1978-11-16
CA1085296A (en) 1980-09-09
NZ183927A (en) 1980-02-21
PL198058A1 (pl) 1979-03-26

Similar Documents

Publication Publication Date Title
DE2813480C2 (de) Arzneimittel-Depotpräparat vom Mehrfacheinheitsdosen-Typ
DE69230112T2 (de) Fortschrittliches arzneistoffabgabesystem und verfahren zur behandlung von psychiatrischen, neurologischen und anderen erkrankungen mit carbamazepin
DE2414868C3 (de) Teilchenförmige Arzneimittel
DE69521987T2 (de) Amoxicillin zweischichttabletten
DE69022876T2 (de) Arzneimittelformulierungen mit verzögerter Wirkstoffabgabe.
DE69003568T2 (de) Arzneimittel mit verzögerter Freigabe.
DE69634171T2 (de) Mikroverkapselte Kaktobacilli für medizinische Anwendungen
DE69331806T2 (de) Multipartikel-arzneistoffabgabesystem mit stossweiser freisetzung
EP1183015B1 (de) Mehrschichttablette zur verabreichung einer fixen kombination von tramadol und diclofenac
EP0977557B1 (de) Pellet-formulierung zur behandlung des intestinaltraktes
DE69319320T2 (de) Arzneimittelzubereitung mit verspätet einsetzender kontinuierlicher Freisetzung
DE1617374C2 (de) Verfahren zum Herstellen eines pharmazeutischen Präparates mit verzögerter analgetischer Wirkung
DE69133348T3 (de) Behandlung von nicht-entzündlichen darmerkrankungen
DE69209080T2 (de) Pharmazeutische zusammemsetzungen mit verzoegerter freigabe
DE1093050B (de) Verfahren zur Herstellung einer Penicillintablette mit verlaengerter Wirkung
DE69521924T2 (de) Pharmazeutische Darreichungsformen mit verzögerter Wirkstoffabgabe enthaltend Alfuzosinhydrochlorid
DE2721785A1 (de) Oral verabfolgbares cephalexinpraeparat mit verzoegerter wirkstoffabgabe
EP0338383B1 (de) Oral zu verabreichende pharmazeutische Zubereitung mit kontrollierter Wirkstofffreisetzung und Verfahren zu deren Herstellung
EP0250648B1 (de) Pharmazeutisches Präparat zur verzögerten Freigabe von Ibuprofen
DE60006362T2 (de) Kapseln mit loratadin und pseudoephedrin enthaltenden zusammensetzungen
EP0994696B1 (de) Kontrolliert freisetzende pharmazeutische zubereitung mit einem ace-hemmer als wirkstoff
CH675208A5 (da)
DE2732335C2 (de) Tablette zur enteralen Verabreichung von Indolyloxyalkanolamin-Derivaten
DE19850445A1 (de) Arzneimittel zur topischen Behandlung entzündlicher Darmerkrankungen
CH677612A5 (da)

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
D2 Grant after examination
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Free format text: TAUCHNER, P., DIPL.-CHEM. DR.RER.NAT. HEUNEMANN, D., DIPL.-PHYS. DR.RER.NAT. RAUH, P., DIPL.-CHEM. DR.RER.NAT. HERMANN, G., DIPL.-PHYS. DR.RER.NAT. SCHMIDT, J., DIPL.-ING. JAENICHEN, H., DIPL.-BIOL. DR.RER.NAT., PAT.-ANWAELTE TREMMEL, H., RECHTSANW., 8000 MUENCHEN